Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suvà ML, Regev A, Bernstein BE (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma, vol 344. Science, New York, N.Y., pp 1396–1401

Google Scholar 

Wan RJ, Peng W, Xia QX, Zhou HH, Mao XY (2021) Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma. CNS Neurosci Ther 27:973–986

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parmigiani E, Ivanek R, Rolando C, Hafen K, Turchinovich G, Lehmann FM, Gerber A, Brkic S, Frank S, Meyer SC, Wakimoto H, Günel M, Louvi A, Mariani L, Finke D, Holländer G, Hutter G, Tussiwand R, Taylor V, Giachino C (2022) Interferon-γ resistance and immune evasion in glioma develop via notch-regulated co-evolution of malignant and immune cells. Dev Cell 57:1847–1865e9

Article  CAS  PubMed  Google Scholar 

Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ, von Mering C (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638–d646

Article  CAS  PubMed  Google Scholar 

Han W, Li C, Wang Y, Huo B, Li W, Shi W (2023) Heme Metabolism-related gene TENT5C is a prognostic marker and investigating its immunological role in Colon cancer. Pharmacogenomics Personalized Med 16:1127–1143

Article  CAS  Google Scholar 

Geeleher P, Cox NJ, Huang RS (2014) Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol 15:R47

Article  PubMed  PubMed Central  Google Scholar 

Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease, vol 313. Science, pp 1929–1935. (New York, N.Y.)

Yang C, Zhang H, Chen M, Wang S, Qian R, Zhang L, Huang X, Wang J, Liu Z, Qin W, Wang C, Hang H, Wang H (2022) A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer. eLife 11

Takano S, Ishikawa E, Matsuda M, Yamamoto T, Matsumura A (2014) Interferon-β inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10. Int J Oncol 45:1837–1846

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zainulabadeen A, Yao P, Zare H (2017) Underexpression of specific Interferon genes is Associated with poor prognosis of Melanoma. PLoS ONE 12:e0170025

Article  PubMed  PubMed Central  Google Scholar 

Han XX, Jin S, Yu LM, Wang M, Hu XY, Hu DY, Ren J, Zhang MH, Huang W, Deng JJ, Chen QQ, Gao Z, He H, Cai C (2022) Interferon-beta inhibits human glioma stem cell growth by modulating immune response and cell cycle related signaling pathways. Cell Regeneration (London England) 11:23

Article  CAS  PubMed  Google Scholar 

Hoekstra ME, Bornes L, Dijkgraaf FE, Philips D, Pardieck IN, Toebes M, Thommen DS, van Rheenen J, Schumacher TNM (2020) Long-distance modulation of bystander tumor cells by CD8(+) T cell-secreted IFNγ. Nat cancer 1:291–301

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding H, Wang G, Yu Z, Sun H, Wang L (2022) Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie 155:113683

Article  CAS  Google Scholar 

Frescaline G, Bouderlique T, Huynh MB, Papy-Garcia D, Courty J, Albanese P (2012) Glycosaminoglycans mimetics potentiate the clonogenicity, proliferation, migration and differentiation properties of rat mesenchymal stem cells. Stem cell Res 8:180–192

Article  CAS  PubMed  Google Scholar 

Aguiar CB, Lobão-Soares B, Alvarez-Silva M, Trentin AG (2005) Glycosaminoglycans modulate C6 glioma cell adhesion to extracellular matrix components and alter cell proliferation and cell migration. BMC Cell Biol 6:31

Article  PubMed  Google Scholar 

Wang L (2016) Mitochondrial purine and pyrimidine metabolism and beyond. Nucleosides Nucleotides Nucleic Acids 35:578–594

Article  CAS  PubMed  Google Scholar 

Basappa KS, Rangappa, Sugahara K (2014) Roles of glycosaminoglycans and glycanmimetics in tumor progression and metastasis. Glycoconj J 31:461–467

Article  CAS  PubMed  Google Scholar 

Nakamizo A, Miyamatsu Y, Hirose H, Amano T, Matsuo S, Fujiwara M, Shimamura T, Yoshimoto K (2022) Metabolic remodeling of pyrimidine synthesis pathway and serine synthesis pathway in human glioblastoma. Sci Rep 12:16277

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang LM, Englander ZK, Miller ML, Bruce JN (2023) Malignant Glioma Adv Experimental Med Biology 1405:1–30

Article  CAS  Google Scholar 

Davis ME (2018) Epidemiology and overview of Gliomas. Semin Oncol Nurs 34:420–429

Article  PubMed  Google Scholar 

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

Article  CAS  PubMed  Google Scholar 

Ghotme KA, Barreto GE, Echeverria V, Gonzalez J, Bustos RH, Sanchez M, Leszek J, Yarla NS, Gomez RM, Tarasov VV, Ashraf GM, Aliev G (2017) Gliomas: New perspectives in diagnosis, treatment and prognosis. Curr Top Med Chem 17:1438–1447

Article  CAS  PubMed  Google Scholar 

Yu R, Zhu B, Chen D (2022) Type I interferon-mediated tumor immunity and its role in immunotherapy. Cell Mol Life Sci 79:191

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lukhele S, Rabbo DA, Guo M, Shen J, Elsaesser HJ, Quevedo R, Carew M, Gadalla R, Snell LM, Mahesh L, Ciudad MT, Snow BE, You-Ten A, Haight J, Wakeham A, Ohashi PS, Mak TW, Cui W, McGaha TL, Brooks DG (2022) The transcription factor IRF2 drives interferon-mediated CD8(+) T cell exhaustion to restrict anti-tumor immunity. Immunity 55:2369–2385e10

Article  CAS  PubMed  PubMed Central  Google Scholar 

Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375–386

Article  CAS  PubMed  Google Scholar 

Lasfar A, Abushahba W, Balan M, Cohen-Solal KA (2011) Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol 2011:349575

Article  PubMed  PubMed Central  Google Scholar 

Tarassishin L, Lee SC (2013) Interferon regulatory factor 3 alters glioma inflammatory and invasive properties. J Neurooncol 113:185–194

Article  CAS  PubMed  Google Scholar 

Garrison JI, Berens ME, Shapiro JR, Treasurywala S, Floyd-Smith G (1996) Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines. J Neurooncol 30:213–223

Article  CAS  PubMed  Google Scholar 

Jin X, Kim SH, Jeon HM, Beck S, Sohn YW, Yin J, Kim JK, Lim YC, Lee JH, Kim SH, Kang SH, Pian X, Song MS, Park JB, Chae YS, Chung YG, Lee SH, Choi YJ, Nam DH, Choi YK, Kim H (2012) Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and notch signalling. Brain 135:1055–1069

Article  PubMed  Google Scholar 

Seliger B, Maeurer MJ, Ferrone S (2000) Antigen-processing machinery breakdown and tumor growth. Immunol Today 21:455–464

Article  CAS  PubMed  Google Scholar 

Yang I, Kremen TJ, Giovannone AJ, Paik E, Odesa SK, Prins RM, Liau LM (2004) Modulation of major histocompatibility complex class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme. J Neurosurg 100:310–319

Article  CAS  PubMed